Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
How many comercial construction loans have you had? Most of the times as someone pointed out they come in phases as the money is used.
You're kidding right? From an investment point of view it is not as important for the 80,000 person market here as it is important for the millions in the investor market in the wealthiest country in the world to be exposed to this drug. A lot of investors hear Nigeria and are turned off. This remedies that a bit. Scam drugs aren't spoken about at such conferences.
Besides if we're lucky Pandey's mug shot and Xechem will show up on a major magazine highlighting the medical break through that Nicosan is and money will flow into this company.
In other words after Dallas, "the cat will be out of the bag"....to the investment community at large.
I agree, todays PR was a positive event and more than just fluff. We may not see the full effect of it until after he talks and Xechem gets U.S. media coverage but no matter how you slice it, it adds enormous credibility to this company to the U.S. investment community especially if Pandey's speech is welcomed by his peers in the medical community.
Yes, our boats will be full when revenues start coming in but we don't need revenues to run. Funding news validates revenues and is the last big hurdle to cross for the company.
Gap filled on shake up it goes now. IMO
Or: pfrenz = only poster that sold = low volume :)
Slow and steady climb could make flippers less of an issue. They may gradually get weeded out as we go up instead of the sudden drop we'd see when they all sell if we had shot right up to begin with. After they see there is no drop the flippers might have to become chasers or subtle bashers predicting a slight drop in price before we go up again... Plus if you're a flipper why flip now when you know it will only get better after he speaks.
JMO and hope..
Level 2?
I just filled it out and pasted todays press release in the body of the text box. If enough people do it they might notice it.
This is big. This Dallas event has basically eliminated negators that try to claim this is a scam. Plus we should get some U.S. media coverage of the event itself later this month. The positive residual effect of this event is hard to measure but Xechem will gain enormous credibility as an investment vehicle here in the U.S. in my opinion.
I'm still looking for that pop to .04 and staying there before loan news even comes....
http://biz.yahoo.com/bw/060912/20060912005290.html?.v=1
Xechem Chairman, Dr. Ramesh Pandey, to Present NICOSAN(TM) Story at 34th Annual SCDAA Conference in Dallas
Tuesday September 12, 7:30 am ET
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Sept. 12, 2006--Xechem International, Inc. (OTC BB: XKEM - News) announced today that its Chairman and CEO, Dr. Ramesh C. Pandey, has accepted an invitation to make a presentation on NICOSAN(TM), the Company's promising new sickle cell drug, at the Sickle Cell Disease Association of America's (SCDAA) 34th Annual Conference. The Conference will be held at the Hyatt Regency Hotel in Dallas, Texas, September 27th through September 30th, 2006. More than 500 physicians, researchers, scientists, nurses and others in the medical community from throughout the country and around the world are expected to attend the Conference, which is also expected to draw a number of sickle cell patients and their family members.
ADVERTISEMENT
Dr. Pandey will speak as part of a Special Panel entitled "Treatment Options and Clinical Trials" on "The Nigerian Experience in the Development of a New Anti-Sickling Natural Herbal Drug." The Company will also set up a poster presentation during the Conference that will afford Xechem the opportunity to present to delegates the credible scientific and medical data that demonstrate both the efficacy and non-toxicity of NICOSAN(TM) (named HEMOXIN(TM) in the US).
According to Dr. Pandey, "It is a fortunate coincidence that this prestigious conference is being held so soon after NICOSAN(TM) was approved by Nigerian drug regulators, National Agency for Food and Drug Administration and Control (NAFDAC) and launched in Nigeria for sale on July 6th, 2006, by His Excellency, Chief Olusegun Obasanjo, GCFR, the President and Commander-in-Chief of the Armed Forces of the Federal Republic of Nigeria. I look forward to presenting to the Conference delegates a summary of the very positive developments regarding what we feel is a truly historic drug. Given the few treatment options currently available for sickle cell sufferers, and the proven efficacy and safety of this drug, I have no doubt that the presentation will be favorably received by those in attendance."
About Sickle Cell Disease
Sickle Cell Disease (SCD) is an inherited blood disorder caused by an abnormality in the hemoglobin molecule. Patients with the disease often produce stiff, abnormally shaped red blood cells that often do not flow freely through the blood vessels. This can create clogs in the vessels, which in turn can cut off the flow of normal hemoglobin and oxygen to parts of the body, and can cause severe painful attacks or "crises", damage to various organs and shortened life spans. People with SCD often suffer unpredictable painful crises several times a year lasting from a few hours to a week or more. In the US, there are approximately 80,000 patients with SCD. In Nigeria, that number is believed to be approximately 4 million, with an estimated 10 - 12 million sufferers throughout the African continent. Worldwide, at least 16 million individuals are believed to be afflicted with SCD.
About Xechem
Xechem International is a development stage biopharmaceutical company working on Sickle Cell Disease (SCD), antimalarials, and antiviral (including AIDS), anticancer, antifungal and antibacterial products from natural sources, including microbial and marine organisms. Its focus is on the development of phyto-pharmaceuticals (Natural Herbal Drugs) and other proprietary technologies, including those used in the treatment of orphan diseases. Xechem's mission is to bring relief to the millions of people who suffer from these diseases. Its recent focus and resources have been directed primarily toward the development and launch of NICOSAN(TM) (named HEMOXIN(TM) in the US and Europe) for the prophylactic management of Sickle Cell Disease (SCD). With the recent Nigerian regulatory approval of NICOSAN(TM), Xechem is now scaling-up the commercialization of the drug in Nigeria and making preparations for the pursuit of US FDA and European regulatory approval. In addition to NICOSAN(TM), Xechem is also working on another sickle cell compound, 5-HMF, which it has licensed from Virginia Commonwealth University (VCU).
Forward Looking Statements
This press release contains certain forward looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended, and section 21E of the Securities and Exchange Act of 1934, as amended, which are intended to be covered by safe harbors created hereby. Such forward looking statements involve known and unknown risks and uncertainties.
Contact:
Xechem International, Inc.
Stephen Burg, 707-425-8855
--------------------------------------------------------------------------------
Source: Xechem International, Inc.
OT:Thanks
I am surprised that it didn't follow through today. Maybe tomorrow. Not too disappointed I don't see us going much below where we're at. I'd prefer going up but I can handle sideways movement. In fact I'd guess it will close higher tomorrow than today. We may be in a range between .024 and .028 without positive funding news.
I think given the delay it will run better than last time it ran. I'd like to see a loan this month followed by another next month.
So far I've only accumulated at these levels and haven't flipped.
Not So Smart
Looks like the market wants funding......
Makes two of us....
If the Dallas event is confirmed by a PR I think some buying interest will return and MAY put us as high as .04. based on charts or I would think at least in the .03s.
Since we're sitting at around .025 with only 10 million shares traded that means there is also very little selling interest so I don't think we need that many more buyers to move this.
Also the residual effect of Pandey speaking is hard to measure. That event adds enormous credibility to Nicosan in my opinion.
Of course the loan news is the big one.
Scarecrow, you're a very unhappy person and you have my pity. "Ignores back on"
Have a joyous day.
Smart
I still think we could see a short term pop to .04 based on the pennant on the chart.
I think what you are talking about is a PR that says in short "We got the money!!!" Now that would be like a major astrological event. At least to my bank account....
And I hope it happens this month.....:))
Light, does the pennant reversal still look good? Do we need an immediate break out or can it happen over a few days to a week or so?
I guess we have to wait until afternoon since he is west coast.
I agree. BTW- would the conference be considered a material event?
Guess that means you need to place it at .0251......LOL
Better hurry.....
Maybe you should raise it to .025....:)
Level 2?
Nicosan is a much needed treatment for SCD. It is not a cure. If it were a cure the victim would not have to continue taking it day after day month after month.
Even using your Jesus analogy the diference between a cure and a treatment should be clear. If Jesus were healing a blind man and he had to come and lay his hands on the man everyday for the duration of the man's life in order for him to see that would be a treatment. If he did it once and the man needed no further treatment then it would be a cure.
Please refrain from suggesting Nicosan is a cure because it is not. Also, suggesting that it is a sin to sell a stock, well, just think about that please.
We know what we own and it is the only real treatment for SCD.
Nicosan is similiar to insulin for diabetics. It relieves the symptoms and allows the victim to live a relatively normal life. In no way is it a cure because continued use is required.
Investing in Xechem is like investing in the only company that produces insulin for Diabetics.
Pharma's have no interest in cures because they don't make money on cures they make money on treatments.
We may pop to .04 forming another flag pole especially if we get a PR about Dallas conference.
I'm not a chart expert and consider myself a balanced investor. I think if you use charts as a reflection of what is happening, considering the fundamentals as well, they can be a useful tool even with penny stocks.
In any case I do think the charts are a reflection of a sideways to slightly upwards movement at this time and hopefully a clear reversal in the next two weeks.
Phrenz his language in this post is vulgar please have him banned.
Almost perfect. Have a great weekend.
How is level 2 going into the last 20 minutes?
03 close....
On the bottom of dodostall's post report the TOS violation. He has continually taunted investors here.
I loaded up the cannon on Tuesday. No more dry powder for the moment. I don't think it will need it because it may start using rocket fuel.....
No, I don't think so. This looks like a steady reveral as it is climbing up. I think it will hold and close strong.
Thank you for your insight. I learned a little basic chart reading back in the early nineties trading futures and when you posted about the pattern it confirmed what I suspected. My skill is basic with charts and deals with simple bar chart readings tops, bottoms, penants, things like that.
Light I think you are absolutely right about this. The fundamentals also support it in my opinion.
Not enough volume yet. He might be in but most of his readers couldn't have bought yet we'd have higher volume. Either way we moved up from .023 before his readers bought in in bulk.
On pace for 50 plus million shares traded today and Green so far. Sure better than two days ago in my mind.
Poker, What you consider neutral is what most consider negative. If you are going to complain at least wait till close. This is holding a good price at the moment.
Smart
Yeah I would be happy with anything green. My excitement here is that we do not seem to be trending downward anymore. It is sideways to upwards in my view. Price seems to be holding right now.
Those that say it can't be done should get out of the way of the people doing it.....Green is Green....